Bioprocessing of Human Glioblastoma Brain Cancer Tissue
- 1 April 2010
- journal article
- research article
- Published by SAGE Publications in Tissue Engineering Part A
- Vol. 16 (4) , 1169-1177
Abstract
Solid cancer tumors are thought to arise from aberrant stem cell populations, called cancer stem cells (CSCs). Hence, the development of effective cancer therapies may rely on developing methods that specifically target these cells. However, the scarcity of CSCs in vivo represents a major impediment to such research, as there is an insufficient supply for basic biochemical and genetic analyses. It is therefore necessary to develop methods to expand reproducibly CSC tissue in vitro in a controlled environment. To date, we have developed bioreactor protocols for the suspension culture of an aggressive and deadly type of brain cancer called glioblastoma multiforme (GBM). Human GBM-derived cells achieved a maximum cell density of 2.4 × 106 cells/mL after 24 days under high shear conditions in batch culture conditions. In comparison, fed-batch cultures achieved 4.5 × 106 cells/mL after 32 days. Characterization of bioreactor-expanded cells using both flow cytometry and a differentiation assay indicated that bioreactor-generated human GBM-derived cells have similar characteristics to the initial cell population and achieve >90% CD133 expression. Additionally, genomic characterization indicated that a very small number of key genes were differentially expressed in the bioreactor-expanded GBM-derived cells, thereby conserving the basic nature of the brain cancer tissue in the cell expansion process.Keywords
This publication has 35 references indexed in Scilit:
- CD133 Is a Marker of Bioenergetic Stress in Human GliomaPLOS ONE, 2008
- Comprehensive genomic characterization defines human glioblastoma genes and core pathwaysNature, 2008
- The genomic profile of human malignant glioma is altered early in primary cell culture and preserved in spheroidsOncogene, 2007
- Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesisNature Reviews Cancer, 2007
- CD133+ and CD133− Glioblastoma-Derived Cancer Stem Cells Show Differential Growth Characteristics and Molecular ProfilesCancer Research, 2007
- Brain tumour stem cells: the undercurrents of human brain cancer and their relationship to neural stem cellsPhilosophical Transactions of the Royal Society B: Biological Sciences, 2007
- Cancer Statistics, 2007CA: A Cancer Journal for Clinicians, 2007
- Genome-Wide Analysis of Epigenetic Silencing Identifies BEX1 and BEX2 as Candidate Tumor Suppressor Genes in Malignant GliomaCancer Research, 2006
- Tumour stem cells and drug resistanceNature Reviews Cancer, 2005
- Identification of molecular subtypes of glioblastoma by gene expression profilingOncogene, 2003